arginine and bay-k-8644

Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Arginine; Cavernous Sinus; Cyclic GMP; Dose-Response Relationship, Radiation; In Vitro Techniques; Light; Muscle, Smooth, Vascular; Nitroarginine; Pulmonary Artery; Rabbits; Ultraviolet Rays; Vasodilation

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Pressure; Calcium; Calcium Channels; Histamine; In Vitro Techniques; Indomethacin; Ion Channel Gating; Lung; omega-N-Methylarginine; Potassium; Rats; Rats, Sprague-Dawley; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Arginine; Blood Pressure; Bradykinin; Hypoxia; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Pulmonary Artery; Rats; Rats, Inbred Strains; Stereoisomerism; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Arginine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitro Compounds; Nitroarginine; Nitrophenols; Photochemistry; Sodium Nitrite; Ultraviolet Rays

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Endothelins; Glyburide; Hemodynamics; Liver Cirrhosis, Experimental; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Calcium; Cells, Cultured; Diazoxide; Female; Fetus; Glipizide; Glucose; Glyceraldehyde; Immunohistochemistry; Insulin; Insulin Secretion; Islets of Langerhans; Leucine; Male; Pancreas; Rats; Rats, Wistar; Verapamil

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Amino Acid Oxidoreductases; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Calcium Channels; Desoxycorticosterone; Dose-Response Relationship, Drug; Drug Implants; Hypertension; Male; Mesenteric Artery, Superior; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Stress, Mechanical; Vasoconstriction

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Pressure; Calcium Channel Blockers; Hemodynamics; Hypertension; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Time Factors; Vasoconstrictor Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Animals; Arginine; Calcitonin Gene-Related Peptide; Calcium; Carbazoles; Enzyme Inhibitors; Glyburide; Guinea Pigs; In Vitro Techniques; Indoles; Isoquinolines; Kidney Pelvis; Male; Membrane Potentials; Nitroarginine; Potassium Channels; Ryanodine; Sucrose; Sulfonamides; Terpenes; Tetrodotoxin; Thapsigargin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Anesthetics, Dissociative; Animals; Arachidonic Acid; Arginine; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cromakalim; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ketamine; Lung; Male; Meclofenamic Acid; Morpholines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation; Verapamil

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Glucose; Calcium Channel Agonists; Cell Separation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; Glucose Tolerance Test; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Stimulation, Chemical

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amino Acid Sequence; Arginine; Barium; Calcium; Calcium Channels, L-Type; Cell Line; Green Fluorescent Proteins; Humans; Ions; Isoleucine; Kinetics; Membrane Potentials; Microscopy, Confocal; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Phenotype; Protein Conformation; Protein Structure, Tertiary; Retinal Diseases; Time Factors; Transfection

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Calcium; Calcium Channel Agonists; Calcium Channels, L-Type; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Radiation; Edema; Electromagnetic Fields; Histamine; Inflammation; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Signal Transduction; Time Factors